BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
2975 results:

  • 1. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
    Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
    Sahraoui G; Rahoui N; Driss M; Mrad K
    Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
    Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
    JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in breast cancer: A Randomized Clinical Study.
    Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hinokitiol Inhibits breast cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
    Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
    Xu Y; Yang J; Han X; Gan C; Wei X
    Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
    Lin CJ; Jin X; Ma D; Chen C; Ou-Yang Y; Pei YC; Zhou CZ; Qu FL; Wang YJ; Liu CL; Fan L; Hu X; Shao ZM; Jiang YZ
    Cancer Cell; 2024 Apr; 42(4):701-719.e12. PubMed ID: 38593782
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative breast cancer.
    Zheng SM; Feng YC; Zhu Q; Li RQ; Yan QQ; Teng L; Yue YM; Han MM; Ye K; Zhang SN; Qi TF; Tang CX; Zhao XH; Zhang YY; Xu L; Xu R; Xing J; Baker M; Liu T; Thorne RF; Jin L; Preiss T; Zhang XD; Cang S; Gao JN
    Cancer Res; 2024 May; 84(9):1460-1474. PubMed ID: 38593213
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer.
    Wang Y; Li Y; Jing Y; Yang Y; Wang H; Ismtula D; Guo C
    Sci Rep; 2024 Apr; 14(1):8201. PubMed ID: 38589634
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
    El-Nashar HAS; Al-Azzawi MA; Al-Kazzaz HH; Alghanimi YK; Kocaebli SM; Alhmammi M; Asad A; Salam T; El-Shazly M; Ali MAM
    J Pharm Biomed Anal; 2024 Jul; 244():116121. PubMed ID: 38581932
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer.
    Li Y; Li G; Zuo C; Wang X; Han F; Jia Y; Shang H; Tian Y
    Eur J Med Chem; 2024 Apr; 270():116367. PubMed ID: 38581732
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer.
    Kim YN; Chung YS; Park E; Lee ST; Lee JY
    Sci Rep; 2024 Apr; 14(1):7992. PubMed ID: 38580676
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Zinc-Iron Bimetallic Peroxides Modulate the Tumor Stromal Microenvironment and Enhance Cell Immunogenicity for Enhanced breast cancer Immunotherapy Therapy.
    Lu Y; Chen Y; Hou G; Lei H; Liu L; Huang X; Sun S; Liu L; Liu X; Na J; Zhao Y; Cheng L; Zhong L
    ACS Nano; 2024 Apr; 18(15):10542-10556. PubMed ID: 38561324
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dioon rzedowskii: An antioxidant, antibacterial and anticancer plant extract with multi-faceted effects on cell growth and molecular signaling.
    Negm WA; Elekhnawy E; Mahgoub S; Ibrahim HA; Ibrahim Elberri A; Abo Mansour HE; Mosalam EM; Moglad E; Alzahraa Mokhtar F
    Int Immunopharmacol; 2024 May; 132():111957. PubMed ID: 38554441
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling.
    Amson R; Senff-Ribeiro A; Karafin T; Lespagnol A; Honoré J; Baylot V; Banroques J; Tanner NK; Chamond N; Dimitrov JD; Hoebeke J; Droin NM; Job B; Piard J; Bommer UA; Choi KW; Abdelfatah S; Efferth T; Telerman SB; Geyer FC; Reis-Filho J; Telerman A
    EMBO Rep; 2024 Apr; 25(4):1962-1986. PubMed ID: 38548973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Uncovering the effect and mechanism of Jiawei Xiaoyao Wan in treating breast cancer complicated with depression based on network pharmacology and experimental analysis.
    Bai Y; Niu L; Song L; Dai G; Zhang W; He B; San W; Li S
    Phytomedicine; 2024 Jun; 128():155427. PubMed ID: 38513380
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
    Wang M; Wei Z; Kong J; Zhao H
    Diagn Pathol; 2024 Mar; 19(1):53. PubMed ID: 38509525
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
    Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
    Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Conditional generative adversarial network driven radiomic prediction of mutation status based on magnetic resonance imaging of breast cancer.
    Huang ZH; Chen L; Sun Y; Liu Q; Hu P
    J Transl Med; 2024 Mar; 22(1):226. PubMed ID: 38429796
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 149.